Status:

UNKNOWN

Impact of Non-surgical Periodontal Therapy in the Management of Plaque Psoriasis.

Lead Sponsor:

University of Siena

Conditions:

Psoriasis Vulgaris

Psoriasis

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Both periodontitis and plaque psoriasis are non communicable chronic inflammatory diseases. They share genetic polymorphysms (IL-1, IL-6 e TNFalfa) and risk factors (smoking, diabetes, obesity), as we...

Eligibility Criteria

Inclusion

  • diagnosis of plaque psoriasis;
  • diagnosis of untreated periodontitis;
  • presence of at least 20 teeth;
  • age between 18 and 70 years;
  • ability and willingness to give informed consent.

Exclusion

  • inability of unwillingness to give informed consent;
  • patients undergoing periodontal treatment within the last 6 months;
  • patients undergoing immunosuppressive treatments for other systemic diseases;
  • pregnancy or lactation;
  • pts undergoing antibiotic therapy.

Key Trial Info

Start Date :

May 10 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2023

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT05311501

Start Date

May 10 2022

End Date

January 1 2023

Last Update

June 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Azienda Ospedaliero Universitaria Senese

Siena, Italy, 53100

Impact of Non-surgical Periodontal Therapy in the Management of Plaque Psoriasis. | DecenTrialz